In contrast to TNT-1, immune sera from AV-1980R/A vaccinated animals and mAb armanezumab bind not only Tau monomers and small fragments but also the aggregated forms of Tau in the brain extracts from AD patients. This evidence concerns the gene MAPT and Alzheimer disease.